Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A personalized phage cocktail developed by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School is an experimental therapy for treating urinary tract infections caused by drug-resistant bacteria. This treatment involves a combination of specific bacteriophages (viruses that infect and kill bacteria) that are selected based on their effectiveness against the particular bacterial strain isolated from an individual patient. This tailored approach is being investigated in an exploratory clinical study to assess its safety and efficacy as a potential alternative to conventional antibiotics that have become ineffective.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on personalized phage cocktail.